Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mannhold

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmazie in Unserer Zeit|June 1, 1995
[Calcium antagonists of the dihydropyridine type: pharmaceutical chemistry and molecular pharmacology]R Mannhold
Arzneimittel-Forschung|December 1, 1988
Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverineR Mannhold
Archiv Der Pharmazie|November 1, 1986
[Analysis of the action of cardio-active drugs]R Mannhold, R Kaufmann
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Putative therapeutic applications of calmodulin antagonistsR Mannhold, H Timmerman
Pharmatherapeutica|January 1, 1987
Fendiline: a review of its basic pharmacological and clinical propertiesR Bayer, R Mannhold
European Journal of Pharmacology|October 4, 1989
Characterization, localization and pharmacological profile of a high-affinity [3H]lidocaine binding siteW Voigt, R Mannhold
Journal of Computer-Aided Molecular Design|May 15, 2001
Substructure and whole molecule approaches for calculating log PR Mannhold, H van de Waterbeemd
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 1975
Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomersR Bayer, R Kaufmann, R Mannhold
Therapie Der Gegenwart|June 1, 1981
[Calcium antagonists: use with discretion]R Bayer, R Mannhold, R Rodenkirchen
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1986
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heartA Goll, H Glossmann, R Mannhold
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmazie in Unserer Zeit|June 1, 1995
[Calcium antagonists of the dihydropyridine type: pharmaceutical chemistry and molecular pharmacology]R Mannhold
Arzneimittel-Forschung|December 1, 1988
Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverineR Mannhold
Archiv Der Pharmazie|November 1, 1986
[Analysis of the action of cardio-active drugs]R Mannhold, R Kaufmann
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Putative therapeutic applications of calmodulin antagonistsR Mannhold, H Timmerman
Pharmatherapeutica|January 1, 1987
Fendiline: a review of its basic pharmacological and clinical propertiesR Bayer, R Mannhold
European Journal of Pharmacology|October 4, 1989
Characterization, localization and pharmacological profile of a high-affinity [3H]lidocaine binding siteW Voigt, R Mannhold
Journal of Computer-Aided Molecular Design|May 15, 2001
Substructure and whole molecule approaches for calculating log PR Mannhold, H van de Waterbeemd
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 1975
Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomersR Bayer, R Kaufmann, R Mannhold
Therapie Der Gegenwart|June 1, 1981
[Calcium antagonists: use with discretion]R Bayer, R Mannhold, R Rodenkirchen
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1986
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heartA Goll, H Glossmann, R Mannhold
Pageof 4